Envestnet Asset Management Portfolio holdings
Envestnet Asset Management, a subsidiary of Envestnet, Inc., founded in 1999 by Jud Bergman and Bill Crager, is a Chicago-based financial technology firm that provides wealth management solutions and software to financial advisors and institutions, managing over $426 billion in discretionary assets as of late 2024. Headquartered at 35 East Wacker Drive, it serves a vast network, including over 111,000 advisors and major U.S. banks, with a platform overseeing more than $6.5 trillion in assets, offering tools like portfolio management, trading, and reporting through an integrated ecosystem. Known for its innovative AdvisorSuite software and Portfolio Management Consultants (PMC) division, Envestnet supports advisors with sub-advisory services, research, and data analytics, bolstered by its 2015 acquisition of Yodlee for enhanced data aggregation. Recently acquired by a Bain Capital-led consortium for $4.5 billion in November 2024, Envestnet continues to evolve as a private entity, focusing on scalable, tech-driven wealth management solutions.
Top Buys
| 1 |
iShares Global Financials ETF
IXG
|
+$879M |
| 2 |
SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$694M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$643M |
| 4 |
iShares Core Total USD Bond Market ETF
IUSB
|
+$589M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$476M |
Top Sells
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$787M |
| 2 |
iShares Global Tech ETF
IXN
|
+$415M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$414M |
| 4 |
iShares US Medical Devices ETF
IHI
|
+$378M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$338M |
Sector Composition
| 1 | Technology | 6.32% |
| 2 | Healthcare | 4.18% |
| 3 | Financials | 3.97% |
| 4 | Consumer Discretionary | 3.02% |
| 5 | Industrials | 2.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
AutoZone
AZO
$71.1B
| $42.5M | 0.02% |
28,467
+1,856
| +7% | +$2.77M |
|
502
ARK Innovation ETF
ARKK
$7.12B
| $42.3M | 0.02% |
323,515
+6,125
| +2% | +$801K |
|
503
Ares Management
ARES
$39.3B
| $42.2M | 0.02% |
663,813
+45,026
| +7% | +$2.86M |
|
504
Dominion Energy
D
$50.7B
| $42M | 0.02% |
570,937
-41,992
| -7% | -$3.09M |
|
505
SPDR Portfolio TIPS ETF
SPIP
$988M
| $41.9M | 0.02% |
1,346,596
+140,055
| +12% | +$4.36M |
|
506
TransUnion
TRU
$17.5B
| $41.7M | 0.02% |
380,029
+17,051
| +5% | +$1.87M |
|
507
RPM International
RPM
$16B
| $41.7M | 0.02% |
470,293
+33,624
| +8% | +$2.98M |
|
508
HP
HPQ
$26.5B
| $41M | 0.02% |
1,357,353
+283,520
| +26% | +$8.56M |
|
509
Gartner
IT
$17.6B
| $41M | 0.02% |
169,085
-24,828
| -13% | -$6.01M |
|
510
Williams Companies
WMB
$71.8B
| $40.9M | 0.02% |
1,539,620
+787,336
| +105% | +$20.9M |
|
511
Kinder Morgan
KMI
$60.8B
| $40.5M | 0.02% |
2,223,225
+262,844
| +13% | +$4.79M |
|
512
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$946M
| $40.5M | 0.02% |
398,383
+271,109
| +213% | +$27.6M |
|
513
Aflac
AFL
$57.3B
| $40.3M | 0.02% |
751,160
-8,263
| -1% | -$443K |
|
514
HEICO Class A
HEI.A
$35B
| $40M | 0.02% |
321,873
+21,485
| +7% | +$2.67M |
|
515
Teladoc Health
TDOC
$1.32B
| $39.9M | 0.02% |
239,970
+68,049
| +40% | +$11.3M |
|
516
iShares Interest Rate Hedged Corporate Bond ETF
LQDH
$506M
| $39.8M | 0.02% |
413,792
+37,684
| +10% | +$3.63M |
|
517
Invesco Fundamental High Yield Corporate Bond ETF
PHB
$354M
| $39.7M | 0.02% |
2,033,520
+138,774
| +7% | +$2.71M |
|
518
Toyota
TM
$257B
| $39.7M | 0.02% |
227,119
+1,758
| +0.8% | +$307K |
|
519
Northern Trust
NTRS
$24.2B
| $39.5M | 0.02% |
341,964
+3,743
| +1% | +$433K |
|
520
Restaurant Brands International
QSR
$20.3B
| $39.5M | 0.02% |
612,869
-23,443
| -4% | -$1.51M |
|
521
iShares Russell 3000 ETF
IWV
$16.8B
| $39.4M | 0.02% |
153,955
-24,797
| -14% | -$6.35M |
|
522
National Grid
NGG
$70.1B
| $39.3M | 0.02% |
685,788
+9,960
| +1% | +$571K |
|
523
Cintas
CTAS
$81.2B
| $39.3M | 0.02% |
411,752
-20,544
| -5% | -$1.96M |
|
|
AVLR
524
DELISTED
Avalara, Inc.
AVLR
| $39.3M | 0.02% |
242,690
+108,506
| +81% | +$17.6M |
|
525
Vertex Pharmaceuticals
VRTX
$99.6B
| $39.3M | 0.02% |
194,744
-13,933
| -7% | -$2.81M |
|